GlassScriptPhysician profile
Jaclyn E Vander Schilden
NPI 1336502665
$384.08
in general payments reported to CMS, 2019-2025
8 companies · $98.80 in 2025
The $98.80 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $177 · 2024: $108 · 2025: $98.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $182.04 | 2023-2025 | Echelon; Endopath, Echelon Endopath, Stratafix |
| Polynovo North America LLC | $69.18 | 2024-2025 | Novosorb Btm |
| Davol INC. | $37.31 | 2023 | Progel Applicator Spray Tips |
| Kci USA, INC. | $29.85 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Kerecis Limited | $20.77 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Takeda Pharmaceuticals U.S.A., INC. | $15.80 | 2023 | Gattex |
| Kowa Pharmaceuticals America, INC. | $14.86 | 2023 | Seglentis |
| Silk Road Medical, INC. | $14.27 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Vander Schilden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.